Stocksigma LogoStocksigma Logo

Asston Pharmaceuticals Board to Consider H1 FY27 Results on 12th Nov'26

Asston Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 12th Nov'26 to consider and approve the unaudited financial statements

Asston Pharmaceuticals Board to Consider H1 FY27 Results on 12th Nov'26

Asston Pharmaceuticals Ltd 路 Intimation 路 12 Nov 2026, 5:30 am

Asston Pharmaceuticals Board to Consider H1 FY27 Results on 12th Nov'26 Asston Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 12th Nov'26 to consider and approve the unaudited financial statements along with the limited review report for the half-year ended 30th Sep'26, alongside other incidental matters.

Original exchange filing (PDF)

More announcements from Asston Pharmaceuticals Ltd

All Asston Pharmaceuticals Ltd announcements